GSK boosts plant job cuts by 20

GlaxoSmithKline has tagged as redundant another 20 positions at its Ulverston, UK, manufacturing plant. The cuts were scheduled to be made Monday.

The plant has been under renovation at the same time the staff cuts were announced. The 2008 plan calls for an existing staff of 540 to be cut to less than 250. To make the cuts possible, GSK planned to outsource some intermediates manufacturing and update the plant and equipment. Ulverston was to retain its "specialist sterile manufacture and oral spraying technologies," according to a UK press report.

The number of cuts would have been higher. But some have been forestalled by production issues stemming from bad winter weather and a delayed product development contract.

- here's the article

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.